FDA Inspection
Pharmaceutics International IncPharmaceutics International Inc – FDA Inspection, Dec 6, 2024
Record Details
This FDA Inspection record concerns Pharmaceutics International Inc, with an inspection on December 6, 2024, issued by the Baltimore District Office, covering human drugs.
View Company Profile
ID · a079c214-ff04-4388-aa69-9ebbc2076367
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1251950
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.160(b)(4)Establishment of calibration procedures
- 21 CFR 211.67(b)(3)Cleaning SOPs/instructions
- 21 CFR 211.84(d)(2)Reports of Analysis (Components)
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pharmaceutics International Inc
13| Date | Classification | Office | Project area |
|---|---|---|---|
| November 14, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 29, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 10, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 9, 2018 | VAI | Center for Drug Evaluation and Research | New Drug Evaluation |
| November 16, 2017 | VAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
Other documents for Pharmaceutics International Inc
- FDA Inspection 1194130 - 2022-11-14
- FDA Inspection 1155001 - 2021-09-29
- FDA Inspection 1124614 - 2020-07-10
- FDA Inspection 1071297 - 2018-11-09
- FDA Inspection 1031480 - 2017-11-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.